Sola Diagnostics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $2.91M

  • Investors
  • 4

Sola Diagnostics General Information

Description

Developer of an epigenetic diagnostics platform designed to transform early detection and prevention of women's cancers. The company offers clinically validated molecular tests, real-time risk stratification, and self-sample compatibility through personalized, minimally invasive testing, enabling healthcare providers and women worldwide to detect disease earlier, reduce unnecessary procedures, and implement tailored prevention strategies.

Contact Information

Website
www.sola-diagnostics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • C/o Health Hub Tirol
  • Exlgasse 24
  • Innsbruck, 6020
  • Austria
+43 0676
Primary Industry
Diagnostic Equipment
Other Industries
Clinics/Outpatient Services
Biotechnology
Therapeutic Devices
Vertical(s)
LOHAS & Wellness, FemTech, HealthTech, Life Sciences, Oncology
Corporate Office
  • C/o Health Hub Tirol
  • Exlgasse 24
  • Innsbruck, 6020
  • Austria
+43 0676

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sola Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 01-Aug-2025 $2.91M Completed Generating Revenue
3. Seed Round 01-Jan-2022 Completed Generating Revenue
2. Seed Round 01-Jan-2021 Completed Generating Revenue
1. University Spin-Out 01-Jan-2020 Completed Generating Revenue
To view Sola Diagnostics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Sola Diagnostics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institute for Health and Care Research Government
UCL Ventures University Minority
University of Innsbruck University Minority
University College London University
To view Sola Diagnostics’s complete investors history, request access »

Ready to get started?

Request a free trial

Sola Diagnostics FAQs

  • When was Sola Diagnostics founded?

    Sola Diagnostics was founded in 2020.

  • Where is Sola Diagnostics headquartered?

    Sola Diagnostics is headquartered in Innsbruck, Austria.

  • What industry is Sola Diagnostics in?

    Sola Diagnostics’s primary industry is Diagnostic Equipment.

  • Is Sola Diagnostics a private or public company?

    Sola Diagnostics is a Private company.

  • What is Sola Diagnostics’s current revenue?

    The current revenue for Sola Diagnostics is .

  • How much funding has Sola Diagnostics raised over time?

    Sola Diagnostics has raised $1.53M.

  • Who are Sola Diagnostics’s investors?

    National Institute for Health and Care Research, UCL Ventures, University of Innsbruck, and University College London have invested in Sola Diagnostics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process